Mar 18, 2025
Cats with Hypertrophic Cardiomyopathy: The HALT HCM Study
Principle Investigator Sandra Tou Description This is a blinded, randomized, placebo-controlled clinical field study to provide substantial evidence of effectiveness of a disease modifying drug intervention in the management of ventricular hypertrophy in cats with subclinical Hypertrophic Cardiomyopathy (HCM). The study will consist of up to a 14-day screening period, followed by a 12-month once-weekly…